Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Interest & Investment Income: 2023-2025

Historic Interest & Investment Income for Cross Country Healthcare (CCRN) over the last 3 years, with Q3 2025 value amounting to $864000.0.

  • Cross Country Healthcare's Interest & Investment Income fell 2195.12% to $864000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 6851.43%. This contributed to the annual value of $2.0 million for FY2024, which is 236987.95% up from last year.
  • Per Cross Country Healthcare's latest filing, its Interest & Investment Income stood at $864000.0 for Q3 2025, which was down 2195.12% from $702000.0 recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Interest & Investment Income registered a high of $1.1 million during Q3 2024, and its lowest value of $5000.0 during Q3 2023.
  • Moreover, its 3-year median value for Interest & Investment Income was $535000.0 (2024), whereas its average is $485888.9.
  • In the last 5 years, Cross Country Healthcare's Interest & Investment Income surged by 2204000.0% in 2024 and then tumbled by 2195.12% in 2025.
  • Over the past 3 years, Cross Country Healthcare's Interest & Investment Income (Quarter) stood at $71000.0 in 2023, then skyrocketed by 653.52% to $535000.0 in 2024, then skyrocketed by 61.5% to $864000.0 in 2025.
  • Its Interest & Investment Income stands at $864000.0 for Q3 2025, versus $702000.0 for Q2 2025 and $681000.0 for Q1 2025.